1Ishikawa T, Yanagisawa M, Kimura S, et al. Positive inotropie action of a novel vasoconstrictor peptide endothelin on guinea pig atria[ J]. Am J Physiology, 1988,255 (4 Pt 2 ) : H970-973.
2Shekhar YC, Anand IS, Sarmar R, et al. Effects of prolonged infusion of human Alpha calcitinin gene-related peptid on hemodynamics renal blood flow and hormone levels in C HF[ J]. Am J Cardiol, 1991,67 (8) :732-736.
3Sacca L. Growth hormone :a newcomer in cardiovascular medicine[ J].Cardiovascular Res, 1997,36(1) :3-9.
4Cuneo RC, Wilmshurst P, Lowy C, et al. Cardiac failure responding to growth hormone[J]. Lancet, 1989,1(8642) :838-839.
5Moruzzl P,Dofia E,Agostini PG, et al. Usefulness of L-thyroxin to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy[ J]. Am J Cardiol, 1994,73 (5) : 374-378.
6Kimura T, Kanda T, Kuwabara A, et al. Participation of the pituitarythyroid axis in the cardiovascular system in elderly patients with the CHF[ J] .J Med, 1997,28(1-2) :75-80.
7Martin PY, Abraham WT, Lieming X. Selective v2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with CHF[ J] .J Am Soc Nephrol, 1999,10(10) :2165-2170.
8Meldrum DR. Tumor necrosis factor in the heart [ J ]. Am J Physiol,1998,274(3 ) : 577-595.
9Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure [ J]. J Am Coil Cardiol,2000,35(3) :537-544.
10Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide [ J]. Science, 1992,257(5608) :387-389.
